Continuous taurocholic acid exposure promotes esophageal squamous cell carcinoma progression due to reduced cell loss resulting from enhanced vascular development

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sato, Sho ^a   Yamamoto, Hiroto ^a   Mukaisho, Ken Ichi ^a   Saito, Shota ^a   Hattori, Takanori ^a   Yamamoto, Gaku ^a   Sugihara, Hiroyuki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TAUROCHOLIC ACID; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ASSAY; CELL GROWTH; CELL INVASION; CELL LOSS; CELL MIGRATION; CELL STRUCTURE; CELLULAR SECRETION; CONTROLLED STUDY; DISEASE MODEL; DUODENOGASTRIC REFLUX; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FILOPODIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LONG TERM EXPOSURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; TUMOR CELL LINE; TUMOR GROWTH; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RNA, MESSENGER; TAUROCHOLIC ACID; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84895805537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088831     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156. (Pubitemid 32911406)
2. Nozoe T, Korenaga D, Kabashima A, Sugimachi K (2002) Smoking-related increase of O(6)-methylguanine-DNA methyltransferase expression in squamous cell carcinoma of the esophagus. Cancer Lett 184: 49-55. (Pubitemid 34718106)
3. Yokoyama A, Ohmori T, Muramatsu T, Higuchi S, Yokoyama T, et al. (1996) Cancer screening of upper aerodigestive tract in Japanese alcoholics with reference to drinking and smoking habits and aldehyde dehydrogenase-2 genotype. Int J Cancer 68: 313-316. (Pubitemid 26384133)
4. Dennish GW, Castell DO (1971) Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med 284: 1136-1137.
5. Smit CF, Copper MP, van Leeuwen JA, Schoots IG, Stanojcic LD (2001) Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux. Ann Otol Rhinol Laryngol 110: 190-193. (Pubitemid 32147967)
6. Kadakia SC, Kikendall JW, Maydonovitch C, Johnson LF (1995) Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol 90: 1785-1790.
7. Kaufman SE, Kaye MD (1978) Induction of gastro-oesophageal reflux by alcohol. Gut 19: 336-338. (Pubitemid 8324298)
8. Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, et al. (1987) The effect of alcohol on nocturnal gastroesophageal reflux. JAMA 258: 2077-2079. (Pubitemid 17146750)
9. Hashimoto N, Inayama M, Fujishima M, Ho H, Shinkai M, et al. (2006) Esophageal cancer after distal gastrectomy. Dis Esophagus 19: 346-349. (Pubitemid 44390439)
10. Maeta M, Koga S, Andachi H, Yoshioka H, Wakatsuki T (1986) Esophageal cancer developed after gastrectomy. Surgery 99: 87-91. (Pubitemid 16145525)
11. Shearman DJ, Arnott SJ, Finlayson ND, Pearson JG (1970) Carcinoma of the oesophagus after gastric surgery. Lancet 1: 581-582.
12. Pera M, Trastek VF, Carpenter HA, Fernandez PL, Cardesa A, et al. (1993) Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 55: 1386-1392; discussion 1392-1383.
13. Sears RJ, Champion GL, Richter JE (1995) Characteristics of distal partial gastrectomy patients with esophageal symptoms of duodenogastric reflux. Am J Gastroenterol 90: 211-215.
14. Kumagai H, Mukaisho K, Sugihara H, Bamba M, Miyashita T, et al. (2003) Cell kinetic study on histogenesis of Barrett's esophagus using rat reflux model. Scand J Gastroenterol 38: 687-692. (Pubitemid 36920488)
15. Kumagai H, Mukaisho K, Sugihara H, Miwa K, Yamamoto G, et al. (2004) Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 25: 723-727. (Pubitemid 38618523)
16. Chen KH, Mukaisho K, Sugihara H, Araki Y, Yamamoto G, et al. (2007) High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barrett's esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux model. Cancer Sci 98: 1683-1688. (Pubitemid 47487901)
17. Chen KH, Mukaisho K, Ling ZQ, Shimomura A, Sugihara H, et al. (2007) Association between duodenal contents reflux and squamous cell carcinoma-establishment of an esophageal cancer cell line derived from the metastatic tumor in a rat reflux model. Anticancer Res 27: 175-181.
18. Miwa K, Sahara H, Segawa M, Kinami S, Sato T, et al. (1996) Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67: 269-274. (Pubitemid 26274160)
19. Jürgens S, Meyer F, Spechler SJ, Souza R (2012) The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview. Z Gastroenterol 50: 1028-1034.
20. Tatsugami M, Ito M, Tanaka S, Yoshihara M, Matsui H, et al. (2012) Bile acid promotes intestinal metaplasia and gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev 21: 2101-2107.
21. Song S, Guha S, Liu K, Buttar NS, Bresalier RS (2007) COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 56: 1512-1521. (Pubitemid 350033188)
22. Soma T, Kaganoi J, Kawabe A, Kondo K, Tsunoda S, et al. (2006) Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: A possible mechanism of angiogenesis in patients with esophageal cancer. Int J Cancer 119: 771-782. (Pubitemid 44051440)
23. Dowling RH, Small DM (1968) The effect of pH on the solubility of varying mixtures of free and conjugated bile acids in solution. Gastroenterology 54: 1291.
24. Barthlen W, Libermann-Meffert D, Feussner H, et al. (1994) Effect of pH on human, pig and artificial bile acid preparation. Dis Esophagus 7: 27-30.
25. Graffner H, Florén CH, Nilsson A (1984) Conjugated bile salts in gastric aspirates after gastric resection. Scand J Gastroenterol 19: 116-118. (Pubitemid 14184777)
26. Iftikhar SY, Ledingham S, Steele RJ, Evans DF, Lendrum K, et al. (1993) Bile reflux in columnar-lined Barrett's oesophagus. Ann R Coll Surg Engl 75: 411-416. (Pubitemid 23323448)
27. Fukuchi M, Miyazaki T, Fukai Y, Nakajima M, Sohda M, et al. (2004) Plasma level of transforming growth factor beta1 measured from the azygos vein predicts prognosis in patients with esophageal cancer. Clin Cancer Res 10: 2738-2741. (Pubitemid 38509149)
28. von Rahden BH, Stein HJ, Feith M, Pühringer F, Theisen J, et al. (2006) Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. Mol Carcinog 45: 786-794. (Pubitemid 44484989)
29. Kleespies A, Guba M, Jauch KW, Bruns CJ (2004) Vascular endothelial growth factor in esophageal cancer. J Surg Oncol 87: 95-104. (Pubitemid 39079657)
30. Prins MJ, Verhage RJ, ten Kate FJ, van Hillegersberg R (2012) Cyclooxygenase isoenzyme-2 and vascular endothelial growth factor are associated with poor prognosis in esophageal adenocarcinoma. J Gastrointest Surg 16: 956-966.
31. Silverman SJ, Andrews AW (1977) Bile acids: co-mutagenic activity in the Salmonella-mammalian-microsome mutagenicity test: brief communication. J Natl Cancer Inst 59: 1557-1559. (Pubitemid 8204822)
32. Fein M, Fuchs KH, Stopper H, Diem S, Herderich M (2000) Duodenogastric reflux and foregut carcinogenesis: analysis of duodenal juice in a rodent model of cancer. Carcinogenesis 21: 2079-2084.
33. Lamireau T, Zoltowska M, Levy E, Yousef I, Rosenbaum J, et al. (2003) Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. Life Sci 72: 1401-1411. (Pubitemid 36090124)
34. Perez MJ, Briz O (2009) Bile-acid-induced cell injury and protection. World J Gastroenterol 15: 1677-1689.
35. Heuman DM, Bajaj R (1994) Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 106: 1333-1341.
36. McQuaid KR, Laine L, Fennerty MB, Souza R, Spechler SJ (2011) Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 34: 146-165.
37. Stamp DH (2002) Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy. Med Hypotheses 59: 398-405.
38. Nishioka K, Doki Y, Miyata H, Tamura S, Yasuda T, et al. (2006) Bile acid promotes the proliferation of squamous cell carcinoma of the esophagus, independent of its inducing COX-2 expression. J Surg Res 132: 130-135.
39. Zhang R, Gong J, Wang H, Wang L (2005) Bile salts inhibit growth and induce apoptosis of human esophageal cancer cell line. World J Gastroenterol 11: 5109-5116. (Pubitemid 41410325)
40. Fujita S (1978) Biology of early gastric carcinoma. Pathol Res Pract 163: 297-309.
41. Folkman J (1974) Proceedings: Tumor angiogenesis factor. Cancer Res 34: 2109-2113.
42. Burnat G, Rau T, Elshimi E, Hahn EG, Konturek PC (2007) Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line. Scand J Gastroenterol 42: 1460-1465. (Pubitemid 350125549)
43. Faix J, Rottner K (2006) The making of filopodia. Curr Opin Cell Biol 18: 18-25. (Pubitemid 43107603)
44. Borisy GG, Svitkina TM (2000) Actin machinery: pushing the envelope. Curr Opin Cell Biol 12: 104-112. (Pubitemid 30095276)
45. Small JV (1994) Lamellipodia architecture: actin filament turnover and the lateral flow of actin filaments during motility. Semin Cell Biol 5: 157-163.
46. Small JV, Stradal T, Vignal E, Rottner K (2002) The lamellipodium: where motility begins. Trends Cell Biol 12: 112-120. (Pubitemid 34164650)
47. Gandy KA, Canals D, Adada M, Wada M, Roddy P, et al. (2013) Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins. Biochem J 449: 661-672.
48. Sun J, He H, Xiong Y, Lu S, Shen J, et al. (2011) Fascin protein is critical for transforming growth factor β protein-induced invasion and filopodia formation in spindle-shaped tumor cells. J Biol Chem 286: 38865-38875.
49. Mooradian DL, McCarthy JB, Komanduri KV, Furcht LT (1992) Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J Natl Cancer Inst 84: 523-527.